Shandong Sino-Agri United Biotechnology Co.,Ltd.

SZSE:003042.SZ

17.36 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42017 Q22017 Q12016 Q22016 Q1
Revenue 519.95486.998535.639547.857437.773326.299457.188392.571504.847426.861495.071592.467419.025444.776369.242446.189364.866398.638305.156515.552348.84253.006308.294308.294240.15240.15
Cost of Revenue 453.849426.465482.953476.855401.136351.392413.052357.581407.578337.989397.258486.22303.942272.495283.932382.63276.431301.312231.294381.441260.457170.655205.787205.787171.381171.381
Gross Profit 66.10160.53452.68671.00236.637-25.09344.13534.9997.26988.87297.813106.247115.082172.28185.3163.55888.43597.32573.862134.11188.38382.351102.508102.50868.76968.769
Gross Profit Ratio 0.1270.1240.0980.130.084-0.0770.0970.0890.1930.2080.1980.1790.2750.3870.2310.1420.2420.2440.2420.260.2530.3250.3320.3320.2860.286
Reseach & Development Expenses 7.29538.5279.02928.619.53731.30424.43928.65314.08825.55429.98131.77516.60131.8714.48615.20212.07517.64313.56221.51612.08817.7640000
General & Administrative Expenses 32.636-76.12582.031-8.13137.75-91.887103.597-14.18845.247-89.68975.947-5.11353.659-59.6761.892-4.85241.518-56.6871.192-18.74332.865-111.4335.18135.18125.1625.16
Selling & Marketing Expenses 9.096-18.59529.98712.01911.17418.18819.3915.6067.8879.15614.48312.8538.64714.50710.92812.3877.5949.718.61211.5798.22924.17412.75812.75810.55510.555
SG&A 41.732-94.719112.01938.28247.93-73.698122.9861.41853.134-80.53490.437.7462.306-45.16372.827.53549.112-46.9779.804-7.16441.095-87.25647.93947.93935.71535.715
Other Expenses 9.047190.779-36.106-2.825-0.1580.2881.214-1.057-0.544118.068-35.80538.0461.669-0.1670.287-0.038-0.115-0.0230.015-0.9850.431-0.1040000
Operating Expenses 58.075134.58784.94169.71757.62593.022109.61469.72466.67863.08884.60677.56280.57598.53156.92752.99462.10360.77445.62663.23253.65573.14158.36158.36145.95745.957
Operating Income 8.026-74.054-201.286-20.988-136.288-84.583-38.03921.67310.57311.37937.61640.9359.89623.7963.28121.96223.3145.769.2221.173.81753.05453.05432.78132.781
Operating Income Ratio 0.015-0.152-0.0370.002-0.048-0.418-0.185-0.0970.0430.0250.0230.0630.0980.1350.0640.0070.060.0580.0190.1340.0610.0150.1720.1720.1370.137
Total Other Income Expenses Net 0.020.045-12.9160.026-5.2040.288-0.0490.206-6.7410.227-0.1560.656-5.501-2.207-5.705-6.052-4.4160.2380.015-1.877-7.688-0.104-8.908-8.908-9.968-9.968
Income Before Tax 8.046-74.009-32.916-3.087-26.192-135.999-84.631-37.83321.86910.811.22420.92628.08359.72924.0093.31621.84823.2915.71568.23621.6013.71344.14744.14722.81222.812
Income Before Tax Ratio 0.015-0.152-0.061-0.006-0.06-0.417-0.185-0.0960.0430.0250.0230.0350.0670.1340.0650.0070.060.0580.0190.1320.0620.0150.1430.1430.0950.095
Income Tax Expense 3.987-7.581-9.4697.955-4.656-29.146-10.853-8.9734.848-7.16-2.4463.3524.1497.4610.057-0.753.5380.9090.94610.6542.808-8.8626.5976.5973.1493.149
Net Income 4.059-66.428-23.447-11.042-21.535-106.853-73.778-28.8617.02117.9613.66917.57523.93452.26823.9524.06618.3122.3814.7757.58218.79312.57437.54937.54919.66319.663
Net Income Ratio 0.008-0.136-0.044-0.02-0.049-0.327-0.161-0.0740.0340.0420.0280.030.0570.1180.0650.0090.050.0560.0160.1120.0540.050.1220.1220.0820.082
EPS 0.03-0.478-0.16-0.078-0.15-0.75-0.52-0.20.120.130.130.160.170.370.290.0490.170.270.0570.70.180.150.520.520.290.29
EPS Diluted 0.03-0.478-0.16-0.078-0.15-0.75-0.52-0.20.120.130.130.160.170.370.290.0490.170.270.0570.70.180.150.520.520.290.29
EBITDA 17.117-64.083-21.7649.868-16.52-85.205-35.08311.24370.82259.02958.66756.4269.23299.05558.73735.28552.98155.86339.61496.47255.9149.1571.10171.10147.81247.812
EBITDA Ratio 0.033-0.132-0.0410.091-0.038-0.261-0.0770.0290.140.1380.1190.0950.1650.2230.1590.0790.1450.140.130.1870.160.0360.2310.2310.1990.199